A detailed history of Loomis Sayles & CO L P transactions in Vericel Corp stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,040,070 shares of VCEL stock, worth $61.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,040,070
Previous 1,064,000 2.25%
Holding current value
$61.5 Million
Previous $48.8 Million 9.98%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.25 - $53.56 $1.01 Million - $1.28 Million
-23,930 Reduced 2.25%
1,040,070 $43.9 Million
Q2 2024

Aug 13, 2024

SELL
$41.71 - $52.9 $1.76 Million - $2.24 Million
-42,301 Reduced 3.82%
1,064,000 $48.8 Million
Q1 2024

May 14, 2024

SELL
$32.52 - $52.33 $1.15 Million - $1.84 Million
-35,225 Reduced 3.09%
1,106,301 $57.6 Million
Q4 2023

Feb 13, 2024

SELL
$30.85 - $37.09 $1.11 Million - $1.34 Million
-36,134 Reduced 3.07%
1,141,526 $40.7 Million
Q3 2023

Nov 09, 2023

SELL
$31.69 - $39.25 $1.16 Million - $1.44 Million
-36,755 Reduced 3.03%
1,177,660 $39.5 Million
Q2 2023

Aug 11, 2023

SELL
$29.0 - $38.37 $325,699 - $430,933
-11,231 Reduced 0.92%
1,214,415 $45.6 Million
Q1 2023

May 11, 2023

BUY
$23.85 - $31.34 $5.79 Million - $7.6 Million
242,609 Added 24.68%
1,225,646 $35.9 Million
Q4 2022

Feb 10, 2023

SELL
$17.65 - $27.37 $415,004 - $643,550
-23,513 Reduced 2.34%
983,037 $25.9 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $4.22 Million - $6.07 Million
186,477 Added 22.74%
1,006,550 $23.4 Million
Q2 2022

Aug 05, 2022

BUY
$22.88 - $39.45 $3.81 Million - $6.57 Million
166,533 Added 25.48%
820,073 $20.7 Million
Q1 2022

May 13, 2022

SELL
$31.69 - $43.29 $395,047 - $539,653
-12,466 Reduced 1.87%
653,540 $25 Million
Q4 2021

Feb 14, 2022

BUY
$35.2 - $52.6 $23.4 Million - $35 Million
666,006 New
666,006 $26.2 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.